Arovella Therapeutics Limited (ASX:ALA) Directors Insider Transactions
The Directors and Chief Executives of Arovella Therapeutics Limited (ASX:ALA) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Arovella Therapeutics Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Arovella Therapeutics Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Arovella Therapeutics Limited Directors/Insider Transactions Activity
List of Insider trades activity from Arovella Therapeutics Limited (ALA).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 24 Nov 2025 | Stoner (Elizabeth) | Director (Non-Executive) | 1,157,647 | - | - |
| 12 Nov 2025 | Barton (Debora M.D.) | Director (Non-Executive) | 1,013,333 | - | - |
| 13 Oct 2025 | Baker (Michael) | Chief Executive Officer | 1,617,021 | - | - |
| 01 Jul 2025 | Duthy (Thomas) | Retired | 4,747,444 | - | - |
| 28 Mar 2024 | Duthy (Thomas) | Non Executive Chairman | 103,000 | 9,723 | Purchase at price 0.09 per share. |
| 28 Mar 2024 | Phillips (Gary Jonathan) | Director (Non-Executive) | 66,666 | 6,513 | Purchase at price 0.10 per share. |
| 27 Mar 2024 | Baker (Michael) | Chief Executive Officer | 220,000 | 20,416 | Purchase at price 0.09 per share. |